Public Employees Retirement System of Ohio acquired a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 15,376 shares of the company's stock, valued at approximately $323,000.
Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its stake in Phibro Animal Health by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company's stock worth $31,809,000 after buying an additional 20,604 shares during the period. American Century Companies Inc. boosted its stake in shares of Phibro Animal Health by 18.0% during the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock valued at $13,348,000 after purchasing an additional 96,787 shares in the last quarter. Nuveen Asset Management LLC increased its holdings in Phibro Animal Health by 21.4% during the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock valued at $12,348,000 after buying an additional 103,618 shares during the period. Renaissance Technologies LLC increased its holdings in Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company's stock valued at $11,714,000 after buying an additional 10,600 shares during the period. Finally, Geode Capital Management LLC raised its stake in Phibro Animal Health by 1.7% in the fourth quarter. Geode Capital Management LLC now owns 515,979 shares of the company's stock worth $10,838,000 after buying an additional 8,510 shares in the last quarter. Institutional investors own 99.34% of the company's stock.
Phibro Animal Health Stock Up 0.8%
NASDAQ PAHC traded up $0.19 on Friday, hitting $24.08. The stock had a trading volume of 138,802 shares, compared to its average volume of 203,244. The business's fifty day moving average price is $20.74 and its 200 day moving average price is $21.88. The stock has a market cap of $976.06 million, a price-to-earnings ratio of 50.17, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a 52-week low of $16.16 and a 52-week high of $26.55.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Equities research analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.
Phibro Animal Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.99%. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on PAHC. Barclays increased their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday, May 8th. Finally, Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $20.00.
Check Out Our Latest Report on Phibro Animal Health
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Further Reading
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
